Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 10, 908

Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome


Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome

Robert J Pignolo et al. Front Endocrinol (Lausanne).


Segmental progeroid syndromes are commonly represented by genetic conditions which recapitulate aspects of physiological aging by similar, disparate, or unknown mechanisms. Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease caused by mutations in the gene for ACVR1/ALK2 encoding Activin A receptor type I/Activin-like kinase 2, a bone morphogenetic protein (BMP) type I receptor, and results in the formation of extra-skeletal ossification and a constellation of others features, many of which resemble accelerated aging. The median estimated lifespan of individuals with FOP is approximately 56 years of age. Characteristics of precocious aging in FOP include both those that are related to dysregulated BMP signaling as well as those secondary to early immobilization. Progeroid features that may primarily be associated with mutations in ACVR1 include osteoarthritis, hearing loss, alopecia, subcutaneous lipodystrophy, myelination defects, heightened inflammation, menstrual abnormalities, and perhaps nephrolithiasis. Progeroid features that may secondarily be related to immobilization from progressive heterotopic ossification include decreased vital capacity, osteoporosis, fractures, sarcopenia, and predisposition to respiratory infections. Some manifestations of precocious aging may be attributed to both primary and secondary effects of FOP. At the level of lesion formation in FOP, soft tissue injury resulting in hypoxia, cell damage, and inflammation may lead to the accumulation of senescent cells as in aged tissue. Production of Activin A, platelet-derived growth factor, metalloproteinases, interleukin 6, and other inflammatory cytokines as part of the senescence-associated secretory phenotype could conceivably mediate the initial signaling cascade that results in the intense fibroproliferative response as well as the tissue-resident stem cell reprogramming leading up to ectopic endochondral bone formation. Consideration of FOP as a segmental progeroid syndrome offers a unique perspective into potential mechanisms of normal aging and may also provide insight for identification of new targets for therapeutic interventions in FOP.

Keywords: ACVR1; activin A; cell senescence; fibrodysplasia ossificans progressiva; progeroid syndrome.


Figure 1
Figure 1
Muscle injury-induced senescence. Senescence-associated β-galactosidase (SAβ-gal) staining of the tibialis anterior muscle of a wild-type mouse is shown without injury (left) and 5 days after injury via cardiotoxin (CTX) injection. SAβ-gal-stained cells appear blue. Images are courtesy of Haitao Wang, Ph.D., Mayo Clinic, Rochester, MN, USA).
Figure 2
Figure 2
Potential roles for cellular senescence in FOP lesion formation. The major hypothesized contributions of senescence are through the production of activin A, IL-6, and other components of the SASP. T, inhibitory pathways; T, inhibitory action of senotherapeutic drugs.

Similar articles

See all similar articles


    1. Kirkwood TB. Human senescence. Bioessays. (1996) 18:1009–16. 10.1002/bies.950181211 - DOI - PubMed
    1. Partridge L, Gems D. The evolution of longevity. Curr Biol. (2002) 12:R544–6. 10.1016/S0960-9822(02)01048-5 - DOI - PubMed
    1. Herndon LA, Schmeissner PJ, Dudaronek JM, Brown PA, Listner KM, Sakano Y, et al. . Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature. (2002) 419:808–14. 10.1038/nature01135 - DOI - PubMed
    1. Martin GM. Genetics and aging; the Werner syndrome as a segmental progeroid syndrome. Adv Exp Med Biol. (1985) 190:161–70. 10.1007/978-1-4684-7853-2_5 - DOI - PubMed
    1. Martin GM. Genetic syndromes in man with potential relevance to the pathobiology of aging. Birth Defects Orig Artic Ser. (1978) 14:5–39. - PubMed